New personalized therapy aims to calm dementia symptoms without drugs
NCT ID NCT07356336
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a personalized, non-drug method called CoMBI to reduce troubling behaviors like agitation and anxiety in people with dementia living in nursing homes. Researchers will compare CoMBI to usual care in 60 participants to see if it improves quality of life and reduces stress for caregivers. The approach trains staff to tailor interactions based on each person's unique needs and personality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexianen Zorggroep Tienen
RECRUITINGTienen, Vlaams-Brabant, 3300, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Could sharing lived experiences ease the burden of dementia care?
- A new tool aims to shield dementia patients from neglect
- Brain scans could unlock the hidden timeline of Alzheimer's